Complete blood count reflects the degree of oesophageal varices and liver fibrosis in virus-related chronic liver disease patients

Journal of Viral Hepatitis

Volumn 16, Issue 6, 2009, Pages 444-452

  Lee, J H ^b,c   Yoon, J H ^a,b,c   Lee, C H ^b,d   Myung, S J ^b,c   Keam, B ^b,e   Kim, B H ^b,c   Chung, G E ^b,c   Kim, W ^b,c   Kim, Y J ^b,c   Jang, J J ^a   Lee, H S ^b,c  

^a Seoul National University   (South Korea)

^b Department of Internal Medicine ^*  (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Lung Institute   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Complete blood cell count; Liver fibrosis; Oesophageal varices; P2 MS

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CHRONIC LIVER DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ESOPHAGUS VARICES; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HIGH RISK POPULATION; HISTOLOGY; HUMAN; LEUKOCYTE COUNT; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL; PORTAL HYPERTENSION; PREVALENCE; PRIORITY JOURNAL; THROMBOCYTE COUNT; VALIDATION PROCESS;

ADULT; AGED; BLOOD CELL COUNT; COHORT STUDIES; ESOPHAGUS; FEMALE; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; VARICOSE VEINS;

EID: 65449152203     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01091.x     Document Type: Article

References (26)

1. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005 43 : 167 176. (Pubitemid 40805288)
2. Baik SK, Kim JW, Kim HS et al. Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. Radiology 2006 240 : 574 580. (Pubitemid 44098657)
3. Giannini E, Botta F, Borro P et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 2003 52 : 1200 1205. (Pubitemid 36877436)
4. Giannini EG, Zaman A, Kreil A et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol 2006 101 : 2511 2519. (Pubitemid 44665246)
5. Kim SH, Kim YJ, Lee JM et al. Esophageal varices in patients with cirrhosis: multidetector CT esophagography - comparison with endoscopy. Radiology 2007 242 : 759 768. (Pubitemid 46310088)
6. Dienstag JL. The role of liver biopsy in chronic hepatitis C. Hepatology 2002 36 : S152 S160. (Pubitemid 35253476)
7. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003 38 : 1449 1457. (Pubitemid 37466971)
8. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001 344 : 495 500. (Pubitemid 32164902)
9. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000 32 : 477 481.
10. Maharaj B, Maharaj RJ, Leary WP et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986 1 : 523 525.
11. Castera L, Vergniol J, Foucher J et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005 128 : 343 350. (Pubitemid 40439195)
12. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001 357 : 1069 1075.
13. Lim AK, Patel N, Hamilton G, Hajnal JV, Goldin RD, Taylor-Robinson SD. The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology 2003 37 : 788 794. (Pubitemid 36397389)
14. Liu CH, Hsu SJ, Lin JW et al. Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance index. Clin Gastroenterol Hepatol 2007 5 : 1199 1206 e1.
15. Park GJ, Lin BP, Ngu MC, Jones DB, Katelaris PH. Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis? J Gastroenterol Hepatol 2000 15 : 386 390. (Pubitemid 30262205)
16. Patel K, Gordon SC, Jacobson I et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 2004 41 : 935 942. (Pubitemid 39575660)
17. Sterling RK, Lissen E, Clumeck N et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006 43 : 1317 1325. (Pubitemid 43980111)
18. Wai CT, Greenson JK, Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003 38 : 518 526. (Pubitemid 36919874)
19. Yin M, Talwalkar JA, Glaser KJ et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007 5 : 1207 1213 e2. (Pubitemid 47488968)
20. Paquet KJ. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices - a prospective controlled randomized trial. Endoscopy 1982 14 : 4 5. (Pubitemid 12200691)
21. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996 24 : 289 293.
22. Sanyal AJ, Fontana RJ, Di Bisceglie AM et al. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis. Gastrointest Endosc 2006 64 : 855 864.
23. Qamar AA, Grace ND, Groszmann RJ et al. Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis. Hepatology 2008 47 : 153 159.
24. Vallet-Pichard A, Mallet V, Pol S. FIB-4: a simple, inexpensive and accurate marker of fibrosis in HCV-infected patients. Hepatology 2006 44 : 769 author reply 769 770. (Pubitemid 44433734)
25. Kubota A, Okamura S, Omori F et al. High serum levels of granulocyte-macrophage colony-stimulating factor in patients with liver cirrhosis and granulocytopenia. Clin Lab Haematol 1995 17 : 61 63.
26. Wognum AW, Westerman Y, Visser TP, Wagemaker G. Distribution of receptors for granulocyte-macrophage colony-stimulating factor on immature CD34+ bone marrow cells, differentiating monomyeloid progenitors, and mature blood cell subsets. Blood 1994 84 : 764 774. (Pubitemid 24223870)